Patents by Inventor Carlos Rabito

Carlos Rabito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluorescent agents for real-time measurement of organ function
    Publication number: 20030215391
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Application
    Filed: May 6, 2003
    Publication date: November 20, 2003
    Inventor: Carlos Rabito
  • Fluorescent agents for real-time measurement of organ function
    Publication number: 20030017111
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time-resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Application
    Filed: August 26, 2002
    Publication date: January 23, 2003
    Inventor: Carlos Rabito
  • Fluorescent agents for real-time measurement of organ function
    Patent number: 6440389
    Abstract: A fluorescent agent for monitoring organ function, such as glomerular filtration, renal blood flow, or hepatic function. The agent is injected into a subject and the fluorescence monitored in vivo via time-resolved fluorescent techniques. The agent is a lanthanide ion chelated to a polyaminopolyacetic acid analog. A new clearance agent is also proposed based on a tetraazamacrocycle. Such a clearance agent also finds applications in other fields where fluorescence detection is exploited.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: August 27, 2002
    Assignee: The General Hospital Corporation
    Inventor: Carlos Rabito